for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Medidata Solutions Inc

MDSO.OQ

Latest Trade

91.81USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

60.21

 - 

98.52

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
91.81
Open
--
Volume
--
3M AVG Volume
21.53
Today's High
--
Today's Low
--
52 Week High
98.52
52 Week Low
60.21
Shares Out (MIL)
62.46
Market Cap (MIL)
5,734.12
Forward P/E
49.44
Dividend (Yield %)
--

Next Event

Q3 2019 Medidata Solutions Inc Earnings Release

Latest Developments

More

Medidata Reports Q2 Non-GAAP EPS $0.48 Excluding Items

Catalyst Launches New Multi-solution CRO Powered by the Medidata Rave Clinical Cloud

Phastar Says Enters Technology Partnership With Medidata

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Medidata Solutions Inc

Medidata Solutions Inc. (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company's plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments. Study Design Optimization enables customers to gain visibility into the impact of protocol elements on resource and trial endpoints. Grants Manager compares specific industry benchmarks and analytics, using industry's database of negotiated procedure costs, to support appropriate grants to investigator sites and automated negotiations with multiple investigator sites. Payments enables customers to establish a global investigator payment strategy and process to automate payment calculation, distribution and reporting, including tax and currency exchange calculations.

Industry

Software & Programming

Contact Info

350 Hudson St Fl 9

+1.212.9181800

https://www.medidata.com/

Executive Leadership

Tarek A. Sherif

Chairman of the Board, Chief Executive Officer

Glen M. de Vries

President, Director

Rouven Bergmann

Chief Financial Officer

Michael I. Otner

Executive Vice President, General Counsel, Corporate Secretary

Michael Christopher Pray

Executive Vice President, General Manager - Global Sales

Key Stats

3.00 mean rating - 11 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.5K

2017

0.5K

2018

0.6K

2019(E)

0.7K
EPS (USD)

2016

1.100

2017

1.370

2018

1.710

2019(E)

1.857
Price To Earnings (TTM)
131.86
Price To Sales (TTM)
8.38
Price To Book (MRQ)
8.68
Price To Cash Flow (TTM)
68.23
Total Debt To Equity (MRQ)
13.77
LT Debt To Equity (MRQ)
12.85
Return on Investment (TTM)
5.66
Return on Equity (TTM)
4.05

Latest News

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:

Dassault Systemes targets life sciences with $5.8 billion Medidata deal

France's Dassault Systemes moved to build up its life sciences presence with a $5.8 billion cash deal to buy Medidata Solutions, a U.S. firm focused on clinical trials.

Dassault Systemes to buy Medidata Solutions in $5.8 bln deal

French technology company Dassault Systemes said it had agreed to buy Medidata Solutions, a U.S. software company dealing in the sphere of clinical trials, in a deal worth $5.8 billion on an enterprise value basis.

France's Dassault nears deal to buy healthcare software maker Medidata: CNBC

French technology company Dassault Systemes SE is nearing a deal to acquire U.S.-based software firm for clinical trials Medidata Solutions Inc to boost its life sciences unit, CNBC reported on Tuesday, citing people familiar with the matter.

France's Dassault nears deal to buy health software maker Medidata - CNBC

French technology company Dassault Systemes SE is nearing a deal to acquire U.S.-based software firm clinical trials Medidata Solutions Inc, CNBC reported on Tuesday, citing people familiar with the matter.

BRIEF-Medidata Reports Q1 Gaap Earnings Per Share $0.17

* Q1 EARNINGS PER SHARE VIEW $0.35 -- THOMSON REUTERS I/B/E/S

BRIEF-Medidata Solutions Q4 GAAP Earnings Per Share $0.23

* MEDIDATA REPORTS RECORD FULL-YEAR AND FOURTH QUARTER 2017 RESULTS

BRIEF-Medidata Q3 GAAP earnings per share $0.21

* Q3 revenue $140.1 million versus I/B/E/S view $141.4 million

BRIEF-Worldwide Clinical Trials selects Medidata to streamline clinical site reimbursements

* Worldwide Clinical Trials selects Medidata to streamline clinical site reimbursements across the globe Source text for Eikon: Further company coverage:

BRIEF-Medidata Q1 GAAP earnings per share $0.16

* Q1 revenue $126.8 million versus I/B/E/S view $125.4 million

BRIEF-Medidata posts Q4 adj. earnings $0.33/shr

* Medidata reports record full-year and fourth quarter 2016 results

BRIEF-Medidata Solutions Q3 GAAP earnings per share $0.13

* Q3 earnings per share view $0.26 -- Thomson Reuters I/B/E/S

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up